CNBC TV18 | 20/08/2021 02:18 PM | Click to read full article
American pharma giant Johnson & Johnson (J&J) has moved an application to the Central Drugs Standard Control Organisation (CDSCO) seeking permission to conduct a study of COVID-19 single shot Janssen vaccine in India in adolescents aged 12–17 years.
"India expands its vaccine basket! Johnson and Johnson ’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has five EUA vaccines. This will further boost our nation’s collective fight against COVID-19,” Health Minister Mandaviya had tweeted.